Early detection can change everything in cancer care. David Harding, Senior Vice President of Pipeline Product Management at Abbott, shares how new testing approaches are expanding what’s possible in screening.
A new approach to screening looks for biological signals in blood that could indicate the presence of cancer earlier.
A new blood test called Cancerguard® is aiming to change cancer screening by detecting signals in the body even before symptoms appear, offering broader detection potential when used alongside standard screenings.
New advances in screening are enabling the detection of cancer signals from a single-blood draw, helping guide patients toward the next steps sooner.
George sends Greg to the ‘World of Innovation’ to explore a revolutionary multi-cancer detection test that uses a simple blood draw to help identify signals for over 50 types of cancer.